Effect of bimatoprost on intraocular pressure after cataract surgery

Canadian Journal of Ophthalmology

Volumn 43, Issue 6, 2008, Pages 712-716

  Ünal, Mustafa ^a,b   Yücel, Iclal ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Bimatoprost; Cataract surgery; Intraocular pressure

Indexed keywords

BIMATOPROST; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA THICKNESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

EID: 57749201400     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-150     Document Type: Article

References (41)

1. Thirumalai B, Baranyovits PR. Intraocular pressure changes and the implications on patient review after phacoemulsification. J Cataract Refract Surg 2003;29:504-7.
2. Tranos PG, Wickremasinghe SS, Hildebrand D, et al. Same-day versus first-day review of intraocular pressure after uneventful phacoemulsification. J Cataract Refract Surg 2003;29:508-12.
3. Grinbaum A, Blumenthal M, Assia E. Comparison of intraocular pressure profiles during cataract surgery by phacoemulsification and extracapsular cataract extraction. Ophthalmic Surg Lasers Imaging 2003;34:182-6.
4. Kooner KS, Cooksey JC, Perry P, Zimmerman TJ. Intraocular pressure following ECCE, phacoemulsification, and PC-IOL implantation. Ophthalmic Surg 1988;19:643-6.
5. Ruiz RS, Wilson CA, Musgrove KH, Prager TC. Management of increased intraocular pressure after cataract extraction. Am J Ophthalmol 1987;103:487-91.
6. Shingleton BJ, Wadhwani RA, O'Donoghue MW, Baylus S, Hoey H. Evaluation of intraocular pressure in the immediate period after phacoemulsification. J Cataract Refract Surg 2001;27:524-7.
7. Chan FM, Mathur R, Ku JJ, et al. Short-term outcomes in eyes with posterior capsule rupture during cataract surgery. J Cataract Refract Surg 2003;29:537-41.
8. Hayreh SS. Anterior ischemic optic neuropathy. IV. Occurrence after cataract extraction. Arch Ophthalmol 1980;98:1410-6.
9. Savage JA, Thomas JV, Belcher CD 3rd, Simmons RJ. Extracapsular cataract extraction and posterior chamber intraocular lens implantation in glaucomatous eyes. Ophthalmology 1985;92:1506-16.
10. Fry LL. Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilopine Gel, and Miostat. J Cataract Refract Surg 1992;18:14-9.
11. Ruiz RS, Rhem MN, Prager TC. Effects of carbachol and acetylcholine on intraocular pressure after cataract extraction. Am J Ophthalmol 1989;107:7-10.
12. Byrd S, Singh K. Medical control of intraocular pressure after cataract surgery. J Cataract Refract Surg 1998;24:1493-7.
13. Lai JS, Chua JK, Leung AT, Lam DS. Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg 2000;26:386-91.
14. Ermis SS, Ozturk F, Inan UU. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification. Eye 2005;19:303-7.
15. Onal S, Gozum N, Gucukoglu A. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification. Ophthalmic Surg Lasers Imaging 2005;36:457-62.
16. Scherer WJ, Mielke DL, Tidwell PE, Hauber FA. Effect of latanoprost on intraocular pressure following cataract extraction. J Cataract Refract Surg 1998;24:964-7.
17. Dayanir V, Ozcura F, Kir E, Topaloglu A, Ozkan SB, Aktunc T. Medical control of intraocular pressure after phacoemulsification. J Cataract Refract Surg 2005;31:484-8.
18. Rainer G, Menapace R, Findl O, Petternel V, Kiss B, Georgopoulos M. Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery. J Cataract Refract Surg 2001;27:706-10.
19. Cetinkaya A, Akman A, Akova YA. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification. J Cataract Refract Surg 2004;30:1736-41.
20. Abbasoglu E, Tekeli O, Celikdogan A, Gursel E. A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery. Eur J Ophthalmol 2000;10:27-31.
21. Lai JS, Loo A, Tham CC, Ho SY, Lam DS. Preoperative latanoprost to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg 2001;27:1792-5.
22. Katsimpris JM, Siganos D, Konstas AG, Kozobolis V, Georgiadis N. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification. J Cataract Refract Surg 2003;29:2288-94.
23. Lai JS, Chua JK, Loo A, Ho SY, Lam DS. Effect of intracameral acetylcholine on latanoprost in preventing ocular hypertension after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg 2001;27:700-5.
24. Krauss AH, Woodward DF. Update on the mechanism of action of bimatoprost: a review and discussion of new evidence. Surv Ophthalmol 2004;49:S5-11.
25. Brubaker RF. Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol 2001;45:S347-51.
26. Cantor LB. Clinical pharmacology of bimatoprost. Expert Opin Drug Metab Toxicol 2005;1:151-7.
27. Spada CS, Krauss AH, Woodward DF, et al. Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells. Exp Eye Res 2005;80:135-45.
28. Brubaker RF, Schoff EO, Nau CB, Carpenter SP, Chen K, Vandenburgh AM. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol 2001;131:19-24.
29. Berson FG, Patterson MM, Epstein DL. Obstruction of aqueous outflow by sodium hyaluronate in enucleated human eyes. Am J Ophthalmol 1983;95:668-72.
30. Gross JG, Meyer DR, Robin AL, Filar AA, Kelley JS. Increased intraocular pressure in the immediate postoperative period after extracapsular cataract extraction. Am J Ophthalmol 1988;105:466-9.
31. Mastropasqua L, Carpineto P, Ciancaglini M, Falconio G. Intraocular pressure changes after phacoemulsification and foldable silicone lens implantation using Healon GV. Ophthalmologica 1998;212:318-21.
32. Zamvar U, Dhillon B. Postoperative IOP prophylaxis practice following uncomplicated cataract surgery: a UK-wide consultant survey. BMC Ophthalmol 2005;5:24.
33. Woodward DF, Krauss AH, Chen J, et al. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol 2001;45:S337-45.
34. Maxey KM, Johnson JL, LaBrecque J. The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist. Surv Ophthalmol 2002;47:S34-40.
35. Davies SS, Ju WK, Neufeld AH, Abran D, Chemtob S, Roberts LJ 2nd. Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro. J Ocul Pharmacol Ther 2003;19:45-54.
36. Sharif NA, Kelly CR, Williams GW. Bimatoprost (Lumigan) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca(2+) mobilization studies. Prostaglandins Leukot Essent Fatty Acids 2003;68:27-33.
37. DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol 2001;45:S353-60.
38. Woodward DF, Krauss AH, Chen J, et al. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J Pharmacol Exp Ther 2003;305:772-85.
39. van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177-85.
40. Arici MK, Erdogan H, Toker I, Vural A, Topalkara A. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery. J Ocul Pharmacol Ther 2006;22:34-40.
41. Salvi SM, Soong TK, Kumar BV, Hawksworth NR. Central corneal thickness changes after phacoemulsification cataract surgery. J Cataract Refract Surg 2007;33:1426-8.